Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet, 2023
To support your body during this time, we often recommend lifestyle adjustments
access is currently only appropriate via registered clinical trials
Higher amounts of the GLP-1 hormone than those used in diabetes treatment were found to suppress appetite and bring about feelings of fullness
Let the area dry and try not to touch it again before injecting
You may not see any visual changes, but the structural damage at the molecular level can reduce potency and increase the risk of injection site reactions
US$ 27.45
US$ 27.92
US$ 29.77
US$ 22.85
US$ 23.58
US$ 27.28
